A detailed history of Tower Research Capital LLC (Trc) transactions in Abbott Laboratories stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 33,699 shares of ABT stock, worth $3.87 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
33,699
Previous 118,178 71.48%
Holding current value
$3.87 Million
Previous $12.3 Million 68.71%
% of portfolio
0.1%
Previous 0.21%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $8.45 Million - $9.98 Million
-84,479 Reduced 71.48%
33,699 $3.84 Million
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $8.62 Million - $9.62 Million
85,542 Added 262.11%
118,178 $12.3 Million
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $21.1 Million - $23.3 Million
-192,264 Reduced 85.49%
32,636 $3.71 Million
Q4 2023

Feb 13, 2024

BUY
$90.19 - $110.4 $13.9 Million - $17 Million
153,921 Added 216.85%
224,900 $24.8 Million
Q3 2023

Nov 14, 2023

BUY
$95.53 - $114.62 $4.52 Million - $5.42 Million
47,300 Added 199.76%
70,979 $6.87 Million
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $458,045 - $510,358
-4,545 Reduced 16.1%
23,679 $2.58 Million
Q1 2023

May 09, 2023

SELL
$96.86 - $114.01 $324,577 - $382,047
-3,351 Reduced 10.61%
28,224 $2.86 Million
Q4 2022

Feb 10, 2023

SELL
$95.06 - $111.52 $13.2 Million - $15.5 Million
-138,995 Reduced 81.49%
31,575 $3.47 Million
Q3 2022

Nov 10, 2022

BUY
$96.76 - $112.03 $10 Million - $11.6 Million
103,558 Added 154.54%
170,570 $16.5 Million
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $18.6 Million - $22.5 Million
-182,674 Reduced 73.16%
67,012 $7.28 Million
Q1 2022

May 12, 2022

BUY
$114.02 - $139.04 $15 Million - $18.3 Million
131,537 Added 111.33%
249,686 $29.6 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $9.7 Million - $11.9 Million
83,928 Added 245.25%
118,149 $16.6 Million
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $4.32 Million - $4.78 Million
-37,049 Reduced 51.98%
34,221 $4.04 Million
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $7.98 Million - $9.39 Million
-75,409 Reduced 51.41%
71,270 $8.26 Million
Q1 2021

May 17, 2021

BUY
$108.84 - $128.23 $11.4 Million - $13.5 Million
105,074 Added 252.55%
146,679 $17.6 Million
Q4 2020

Feb 16, 2021

BUY
$105.0 - $114.42 $1.12 Million - $1.22 Million
10,640 Added 34.36%
41,605 $4.56 Million
Q3 2020

Nov 16, 2020

BUY
$91.64 - $111.29 $903,845 - $1.1 Million
9,863 Added 46.74%
30,965 $3.37 Million
Q2 2020

Aug 13, 2020

BUY
$76.57 - $98.0 $374,274 - $479,024
4,888 Added 30.15%
21,102 $1.93 Million
Q1 2020

May 15, 2020

BUY
$62.82 - $91.86 $1.02 Million - $1.49 Million
16,197 Added 95276.47%
16,214 $1.28 Million
Q4 2019

Feb 07, 2020

SELL
$78.51 - $87.4 $1.93 Million - $2.15 Million
-24,549 Reduced 99.93%
17 $1,000
Q3 2019

Nov 05, 2019

BUY
$81.84 - $88.74 $1.73 Million - $1.88 Million
21,168 Added 622.95%
24,566 $2.06 Million
Q2 2019

Aug 13, 2019

SELL
$72.88 - $85.0 $1.25 Million - $1.45 Million
-17,110 Reduced 83.43%
3,398 $286,000
Q1 2019

May 14, 2019

SELL
$66.22 - $80.06 $2.1 Million - $2.54 Million
-31,685 Reduced 60.71%
20,508 $1.64 Million
Q4 2018

Feb 14, 2019

BUY
$65.56 - $74.27 $3.31 Million - $3.75 Million
50,547 Added 3070.9%
52,193 $3.78 Million
Q3 2018

Nov 13, 2018

SELL
$60.81 - $73.36 $4 Million - $4.82 Million
-65,754 Reduced 97.56%
1,646 $121,000
Q2 2018

Aug 15, 2018

BUY
$57.57 - $63.54 $3.32 Million - $3.67 Million
57,736 Added 597.43%
67,400 $4.11 Million
Q1 2018

May 15, 2018

SELL
$56.27 - $63.62 $218,834 - $247,418
-3,889 Reduced 28.69%
9,664 $579,000
Q4 2017

Feb 09, 2018

BUY
$53.68 - $57.47 $383,543 - $410,623
7,145 Added 111.5%
13,553 $773,000
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $307,968 - $343,725
6,408
6,408 $342,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.